We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
292 result(s) found, displaying 81 to 90
-
Australian public assessment report (AusPar)AusPAR for RINVOQ (Upadacitinib) for treatment of atopic dermatitis in patients aged 12 years and above.
-
Australian public assessment report (AusPar)AusPAR for Maviret (glecaprevir /pibrentasvir) for the treatment of adult and paediatric patients with chronic hepatitis C virus.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RINVOQ upadacitinib 30 mg modified release tablet blister pack.
-
-
-
Prescription medicine registrationActive ingredients: upadacitinib hemihydrate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYRIZI risankizumab 150 mg/mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYRIZI risankizumab 150 mg/mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - CoolSculpting Elite - Cryolipolysis skin contouring system.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Contact lens wetting solution.